Home » Newsletters » BioWorld Science

BioWorld Science

June 13, 2016

View Archived Issues

Kalvista Pharmaceuticals patents KLKB1 inhibitors

Novo Nordisk discloses GLP-1 receptor agonists

Acturum Life Science describes mPGES-1 inhibitors

FDA approves Vaxchora cholera vaccine

FDA grants orphan drug designation to fosbretabulin

Cantargia finalizes tests for CAN-04 before applying for clinical trials

Hanmi Pharmaceutical launches olmutinib in South Korea

Yuhan's fibroblast growth factor 21 analogue YH-25348 displays good antidiabetic characteristics

Preliminary phase I data for milatuzumab

Zealand Pharma and Beta Bionics collaborate on new bionic pancreas system

Results from the DRIVE-PK study: treating anemia and hemolysis in pyruvate kinase deficient patients

Agilis gene therapy named FDA orphan drug for aromatic L-amino acid decarboxylase deficiency

Incyte initiates phase I/II study of INCB-057643 in advanced malignancies

BioTime announces a grant for further development of OpRegen

Favorable phase II data on Smac mimetic for primary myelofibrosis

Nexus BioPharma announces the completion of merger

Shire completes European decentralized procedure for immunoglobulin treatment Cuvitru

HDAC6 inhibitor ACY-241 tested in combination with pomalidomide and dexamethasone

FDA awards orphan drug designation to Galena Biopharma's cancer immunotherapy peptide programs

Knockout model reveals role of fibronectin extra domain A sepsis outcomes

Pharmacokinetics/pharmacodynamics of dapagliflozin in pediatric patients with type 2 diabetes

Dr. Reddy's to acquire portfolio of eight ANDAs from Teva

European research project investigates link between gut flora and Alzheimer's disease

Gla-300: meta-analysis of EDITION -1, -2 and -3 studies

FDA grants orphan drug designation to Herantis' recombinant human CDNF

Oral CC-486 well tolerated to date in nasopharyngeal cancer trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...